Parallel Advisors, LLC - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 1 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Parallel Advisors, LLC ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q3 2022$0
-100.0%
2
-99.5%
0.00%
Q4 2021$12,000
+20.0%
409
+2.2%
0.00%
Q3 2021$10,000
-28.6%
4000.0%0.00%
-100.0%
Q2 2021$14,000
-17.6%
400
-5.9%
0.00%0.0%
Q1 2021$17,000
-26.1%
425
-19.4%
0.00%0.0%
Q4 2020$23,000
+4.5%
527
+31.8%
0.00%0.0%
Q3 2020$22,000
-12.0%
4000.0%0.00%
-50.0%
Q2 2020$25,000
+25.0%
4000.0%0.00%0.0%
Q1 2020$20,000
-39.4%
400
-4.5%
0.00%0.0%
Q4 2019$33,000
+37.5%
419
-16.2%
0.00%0.0%
Q3 2019$24,000
-35.1%
500
-28.6%
0.00%
-50.0%
Q2 2019$37,000
+42.3%
700
+40.0%
0.00%
+33.3%
Q1 2019$26,000
+30.0%
5000.0%0.00%0.0%
Q4 2018$20,000
-25.9%
500
-28.6%
0.00%0.0%
Q3 2018$27,000
-12.9%
7000.0%0.00%
-25.0%
Q2 2018$31,000
-8.8%
7000.0%0.00%
-20.0%
Q1 2018$34,000
-20.9%
700
-36.4%
0.01%
-28.6%
Q4 2017$43,0000.0%1,1000.0%0.01%0.0%
Q3 2017$43,000
+48.3%
1,1000.0%0.01%
+40.0%
Q2 2017$29,000
-56.1%
1,100
-50.0%
0.01%
-28.6%
Q1 2017$66,000
+266.7%
2,200
+76.0%
0.01%
+75.0%
Q4 2016$18,0001,2500.00%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q3 2023
NameSharesValueWeighting ↓
Alerce Investment Management, L.P. 356,270$24,262,00023.36%
Twin Securities, Inc. 376,669$25,651,00011.94%
Paradigm Biocapital Advisors LP 1,175,879$80,077,00010.68%
Chicago Capital Management, LLC 246,246$16,769,0009.12%
HARVEST MANAGEMENT LLC 141,500$9,636,0007.78%
Fernwood Investment Management, LLC 174,724$11,899,0005.02%
ArchPoint Investors 168,725$11,490,0004.69%
HAVENS ADVISORS LLC 46,000$3,133,0004.69%
Perceptive Advisors 2,322,247$158,145,0004.59%
Crabel Capital Management, LLC 112,680$7,674,0004.48%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders